WeLeader Biomedical Co., Ltd. (TPEX:7713)

WeLeader Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	2,756	3,243	-	-	-
Enterprise Value	3,095	3,845	-	-	-
Last Close Price	60.60	73.70	-	-	-
PE Ratio	15.31	19.05	-	-	-
PS Ratio	2.75	3.27	-	-	-
PB Ratio	2.66	3.57	-	-	-
P/TBV Ratio	2.67	3.59	-	-	-
P/FCF Ratio	23.19	30.01	-	-	-
P/OCF Ratio	9.82	11.63	-	-	-
EV/Sales Ratio	3.09	3.88	-	-	-
EV/EBITDA Ratio	9.60	15.83	-	-	-
EV/EBIT Ratio	14.71	17.96	-	-	-
EV/FCF Ratio	26.04	35.59	-	-	-
Debt / Equity Ratio	0.69	0.88	0.74	1.09	0.79
Debt / EBITDA Ratio	2.20	2.47	2.07	2.30	1.14
Debt / FCF Ratio	5.97	7.37	5.34	-	1.30
Asset Turnover	-	0.53	0.56	0.83	-
Inventory Turnover	-	8.00	9.71	12.54	-
Quick Ratio	1.16	1.04	0.94	0.89	1.13
Current Ratio	1.37	1.26	1.12	1.04	1.29
Return on Equity (ROE)	17.74%	19.41%	20.41%	30.64%	-
Return on Assets (ROA)	-	7.18%	7.43%	9.80%	-
Return on Capital (ROIC)	8.17%	8.43%	8.78%	12.24%	-
Return on Capital Employed (ROCE)	12.80%	14.00%	14.90%	16.80%	25.50%
Earnings Yield	6.06%	5.25%	-	-	-
FCF Yield	4.31%	3.33%	-	-	-
Dividend Yield	5.56%	4.57%	-	-	-
Payout Ratio	57.28%	56.18%	19.54%	6.35%	21.14%
Buyback Yield / Dilution	-2.60%	-1.55%	-35.00%	-8.28%	-
Total Shareholder Return	2.92%	3.02%	-35.00%	-8.28%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.